Basit öğe kaydını göster

dc.contributor.authorErbas, B
dc.contributor.authorUresin, Y
dc.contributor.authorOzek, M
dc.date.accessioned2021-03-03T19:15:34Z
dc.date.available2021-03-03T19:15:34Z
dc.date.issued2004
dc.identifier.citationUresin Y., Erbas B., Ozek M., "Losartan may prevent the elevation of plasma glucose levels induced by chronic stress", POLISH JOURNAL OF PHARMACOLOGY, cilt.56, sa.2, ss.271-273, 2004
dc.identifier.issn1230-6002
dc.identifier.othervv_1032021
dc.identifier.otherav_538a7f51-8d86-4314-bdb3-99956a28d167
dc.identifier.urihttp://hdl.handle.net/20.500.12627/59229
dc.identifier.urihttps://doi.org/10.3317/jraas.2004.017
dc.description.abstractThe effect of angiotensin II antagonist, losartan, on chronic stress-induced elevation of blood glucose levels was investigated in rats. Chronic immobilization stress caused an increase in blood glucose levels in rats. Administration of losartan (3 mg/kg, po) before stress exposure significantly prevented this increment. We suggest that losartan showed this effect by decreasing the excessive sympathetic response to stress. In conclusion, there is a relationship between stress, sympathetic nervous system, and reninangiotensin system.
dc.language.isoeng
dc.subjectEczacılık
dc.subjectTemel Bilimler
dc.subjectTemel Eczacılık Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectYaşam Bilimleri
dc.titleLosartan may prevent the elevation of plasma glucose levels induced by chronic stress
dc.typeMakale
dc.relation.journalPOLISH JOURNAL OF PHARMACOLOGY
dc.contributor.department, ,
dc.identifier.volume56
dc.identifier.issue2
dc.identifier.startpage271
dc.identifier.endpage273
dc.contributor.firstauthorID171010


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster